Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Biospring Partners closes $245 million first fund as private markets tense up

  • Allison DeAngelis

By Allison DeAngelis June 8, 2022

Reprints
Franklin faces
Adobe

When Michelle Dipp and Jennifer Lum decided to launch a life sciences growth equity fund two years ago, the market looked very different.

The Covid-19 pandemic was driving investors in droves to biotech and pharma companies. Automation and drug manufacturing were becoming hot topics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Allison DeAngelis

Allison DeAngelis

Biotech Startups and Venture Capital Reporter

Allison DeAngelis is a biotech reporter at STAT, covering biopharma startups and venture capital.

Tags

Create a display name to comment

This name will appear with your comment

Common injections don’t help knee osteoarthritis more than placebo,…
Common injections don’t help knee osteoarthritis more than placebo, large data review finds
Why medical school should start at age 28
Why medical school should start at age 28
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: EU delays pharma legislation again; India cancels license…
Pharmalittle: EU delays pharma legislation again; India cancels license for maker of cough syrup linked to…
The surprising biomedical legacy of the Iraq War
The surprising biomedical legacy of the Iraq War

Recommended Stories